港鐵(00066.HK)新列車周日起於觀塘線投入服務
港鐵(00066.HK)宣布,市區線新列車「Q-Train」將於本周日(27日)起於觀塘線投入服務,新列車一共有93架,每列8卡,未來將陸續於港島線、荃灣線及將軍澳線行駛。
新列車內部空間、扶手裝置及座位分佈等將較現行列車有所調整,車內並將設有「智能伺服器」實時傳輸所使用關鍵設備,方便港鐵收集數據,並供工程人員遙距監察、運作及進行預防性保養。
港鐵表示,共斥資60億元向內地中車青島四方機車車輛訂購該93列新列車,預料將全數於2027年前交付,陸續抵港的列車已通過嚴格的試車測試,並獲政府部門確認為安全。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.